35 results
8-K
QTNTQ
Quotient Ltd
29 May 18
Quotient Limited Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Updates on CEO Appointment and MosaiQTM European Field Trials
6:37am
targets determined by the Board (the "Annual Bonus");
subject to the condition that the Company's shareholders approve an amendment during 2018
8-K
EX-99.1
QTNTQ
Quotient Ltd
30 Jan 15
Quotient and Ortho Clinical Diagnostics Establish Exclusive Commercial Partnership
12:00am
by Quotient will increase as a percentage of net sales, subject to the achievement of agreed-upon revenue targets. In addition, a basis for calculating
S-8
EX-4.2
QTNTQ
Quotient Ltd
30 Mar 21
Registration of securities for employees
4:55pm
to the Company’s 2024 fiscal year (“Fiscal Year 2024 Revenue”), as determined by the Committee, as follows:
[Revenue-based performance targets set
8-K
QTNTQ
Quotient Ltd
30 Jan 15
Quotient and Ortho Clinical Diagnostics Establish Exclusive Commercial Partnership
12:00am
existing OCD product lines. In the event that OCD is unable to achieve certain net sales targets set forth in the Distribution and Supply Agreement
424B3
8c62xgb3 h4sb
30 Jan 15
Prospectus supplement
12:00am
8-K
EX-99.1
nhh9qzpi2a1
28 May 19
CE mark received on the initial Immunohematology microarray in April 2019
7:34am
8-K
EX-99.1
36m yjj7r7co4
31 Jan 19
Development data provides positive results for extended IH microarray panel
8:25am
424B3
qq8 cjpuws8f
30 Jan 15
Prospectus supplement
12:00am
8-K
EX-99.1
l0iw2h61f o75
5 Aug 21
Quotient Limited Provides First Quarter Fiscal 2022 Results and Business Update
6:39am
8-K
0hqpsfbuny420n4ar
1 Mar 21
Departure of Directors or Certain Officers
8:01am